Tag: ZanthoSyn

Cardax Refocuses on ZanthoSyn® Consumer Health Business

Company focusing on consumer revenue growth with reduced cost structure Pharmaceutical assets may be monetized through licensing or sale Other strategic alternatives under consideration Board of Directors restructured in connection with new strategy HONOLULU, Aug. 31, 2021 /PRNewswire/ — Cardax, Inc., announced today that it is refocusing its business strategy on its […]